Cardium Therapeutics Inc.
12255 El Camino Real
Suite 250
San Diego,
CA 92130
United States - Map
Phone: 858-436-1000
Fax: 858-436-1001
Web Site: http://www.cardiumthx.com
| Index Membership: | N/A | | Sector: | N/A | | Industry: | N/A | | Full Time Employees: | 43 |
|
| Cardium Therapeutics, Inc. focuses on the acquisition and development of innovative bio-medical product opportunities and businesses that have the potential to address unmet medical needs and definable pathways to commercialization, partnering, and other economic monetizations. The companys investment portfolio includes the Tissue Repair Company and Cardium Biologics, which are medical technology companies primarily focused on the development of innovative therapeutic products for tissue repair and cardiovascular indications. Its products include Generx, a DNA-based growth factor therapeutic that is in Phase III clinical stage designed to leverage the bodys natural healing processes in response to repeated ischemic stress; Corgentin, a pre-clinical stage product, which enhances myocardial healing in and around the infarct zone when used as an adjunct to existing vascular-directed pharmacologic and interventional therapies; and Excellarate, a tissue repairs product candidate that is in Phase IIb clinical trial for the treatment of non-healing diabetic foot ulcers. The company was founded in 2003 and is headquartered in San Diego, California. |
|
| Key Statistics |
| |
| | Pay | Exercised | Mr. Christopher J. Reinhard , 54
Co-Founder, Exec. Chairman, Chief Exec. Officer, Pres and Treasurer |
$
359.00K | N/A | Dr. Tyler M. Dylan PH.D., J.D., 47
Co-Founder, Chief Bus. Officer, Gen. Counsel, Exec. VP, Sec. |
$
334.00K | N/A | Mr. Dennis M. Mulroy , 53
Chief Financial Officer and Principal Accounting Officer |
$
207.00K | N/A | Mr. Mike Magers M.S., M.B.A., 60
Pres of Innercool Therapies, Inc. and Chief Operating Officer of Innercool Therapies, Inc. |
$
274.00K | N/A | Dr. Gabor M. Rubanyi M.D., Ph.D.,, 62
Chief Scientific Officer and Chairman of Scientific Advisory Board |
$
309.00K | N/A |
|
|
|
Dollar amounts are as of
31-Dec-08
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
0.43% Nasdaq 
Profile
